These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 15507287)

  • 41. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
    Galli M; Borrelli G; Jacobsen EM; Marfisi RM; Finazzi G; Marchioli R; Wisloff F; Marziali S; Morboeuf O; Barbui T
    Blood; 2007 Aug; 110(4):1178-83. PubMed ID: 17440049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiphospholipid antibodies--we are not quite there yet.
    Urbanus RT; de Groot PG
    Blood Rev; 2011 Mar; 25(2):97-106. PubMed ID: 21242018
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiphospholipid syndromes with anti-human beta 2-glycoprotein I antibodies despite negative reactivity in conventional aPL and LA assays.
    Guérin V; Couchouron A; Vergnes C; Parrens E; Vernhes JP; Constans J; Boisseau M
    Thromb Haemost; 1997 May; 77(5):1037-8. PubMed ID: 9184427
    [No Abstract]   [Full Text] [Related]  

  • 46. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Standardization of antiphospholipid antibody assays. Where do we stand?
    Devreese KM
    Lupus; 2012 Jun; 21(7):718-21. PubMed ID: 22635211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of lupus anticoagulants in clinical samples using anti-beta2GP1 and anti-prothrombin monoclonal antibodies.
    Le Querrec A; Arnout J; Arnoux D; Borg JY; Caron C; Darnige L; Delahousse B; Reber G; Sié P
    Thromb Haemost; 2001 Aug; 86(2):584-9. PubMed ID: 11522007
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Lupus anticoagulants versus antiphospholipid antibodies].
    Pereira MI
    Acta Med Port; 1998 Apr; 11(4):349-57. PubMed ID: 9644846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet activation rather than endothelial injury identifies risk of thrombosis in subjects positive for antiphospholipid antibodies.
    Jy W; Tiede M; Bidot CJ; Horstman LL; Jimenez JJ; Chirinos J; Ahn YS
    Thromb Res; 2007; 121(3):319-25. PubMed ID: 17582471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome.
    Cucnik S; Bozic B; Kveder T; Tomsic M; Rozman B
    Ann N Y Acad Sci; 2005 Jun; 1051():141-7. PubMed ID: 16126953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC; Quéré I; Sanmarco M; Boutiere B; Mercier E; Amiral J; Hubert AM; Ripart-Neveu S; Hoffet M; Tailland ML; Rousseau O; Monpeyroux F; Dauzat M; Sampol J; Daures JP; Berlan J; Marès P
    Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
    Kumar KS; Jyothy A; Prakash MS; Rani HS; Reddy PP
    J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity.
    Pengo V; Biasiolo A; Bison E; Chantarangkul V; Tripodi A;
    Thromb Res; 2007; 120(1):127-33. PubMed ID: 17020782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome?
    Jara LJ; Medina G; Cruz-Cruz P; Olivares-Rivera J; Duarte-Salazar C; Saavedra MA
    Isr Med Assoc J; 2017 Jun; 19(6):382-386. PubMed ID: 28647939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiphospholipid syndrome. Current insights into laboratory diagnosis and pathophysiology.
    van Os GM; Urbanus RT; Agar C; Meijers JC; de Groot PG
    Hamostaseologie; 2010 Aug; 30(3):139-43. PubMed ID: 20680233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
    Marai I; Tincani A; Balestrieri G; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnosis of the antiphospholipid syndrome.
    Pengo V; Ruffatti A; Iliceto S
    Pathophysiol Haemost Thromb; 2006; 35(1-2):175-80. PubMed ID: 16855367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.